Lower plasma adiponectin concentrations were associated with an increased risk of KRAS-mutated, and not KRAS wild type, CRC in a previous investigation of 307 CRC cases and 2:1 matched controls nested within the Nurses’ Health Study and Health Professionals Follow-up Study23. Here, ADIPOQ is linked to colorectal carcinoma.